ADC Therapeutics S.A. (ADCT)
NYSE·Healthcare·Biotechnology
$1.57
+3.97%
Mkt Cap $204.27M
Analyst Ratings
Buy
3
Hold
1
Sell
0
Price Target (9 analysts)
$3.50
Range $2.00 – $5.00
Implied Upside
+122.9%
Consensus $3.50 vs current $1.57
NYSE·Healthcare·Biotechnology
$1.57
+3.97%
Mkt Cap $204.27M
Buy
3
Hold
1
Sell
0
Price Target (9 analysts)
$3.50
Range $2.00 – $5.00
+122.9%
Consensus $3.50 vs current $1.57